Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991
International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016
Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis
Arch Neurol 64:1792-1794,1794, Chavis,P.S.,et al, 2007
Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy
Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007
Thymoma in Patients with MG
Neurol 59:1844-1850, Evoli,A.,et al, 2002
Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980
Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978
Long-term Administration of Corticosteroids in Myasthenia Gravis
Neurol 26:729, Mann,J.D.,et al, 1976